MEDICA, November 16-19, Düsseldorf, Germany

October 26 2011  by BioPorto Diagnostics

The world’s largest medical trade fair, MEDICA, introduces a wide variety of innovations and know-how in the world of healthcare.

BioPorto Diagnostics will be represented at MEDICA, promoting The NGAL Test™, designed for measuring the emerging biomarker NGAL.

What is NGAL?

NGAL is a biomarker for diagnosing acute kidney injury (AKI). The biomarker has been recognised by the market as a new way to identify patients at risk of developing potentially severe acute kidney injury (AKI).

Meet BioPorto Diagnostics representatives at stand K88, Hall 3, or contact us prior to the congress for an appointment at info@bioporto.com

For further information on MEDICA, please click here

BioPorto - Grusbakken 8, DK-2820 Gentofte, Denmark
Phone: (+45) 4529 0000 - Fax: (+45) 4529 0001 - Email: info@bioporto.com

Created by Wizkids ApShttp://wizkids.dk